RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Hansoh Pharmaceutical Group Company Stock

Hansoh Pharmaceutical Group Company ROCE 2024

Hansoh Pharmaceutical Group Company ROCE

0.1

Ticker

3692.HK

ISIN

KYG549581067

WKN

A2PLRC

In 2024, Hansoh Pharmaceutical Group Company's return on capital employed (ROCE) was 0.1, a -9.43% increase from the 0.11 ROCE in the previous year.

Hansoh Pharmaceutical Group Company Aktienanalyse

What does Hansoh Pharmaceutical Group Company do?

The Hansoh Pharmaceutical Group Co Ltd is a leading company in the pharmaceutical industry in China. It was founded in 1995 and has its headquarters in Lianyungang, with branches in Beijing and Shanghai. The company specializes in developing and producing innovative drugs for various diseases. It invests significant resources in research and development, collaborating with renowned research institutes and universities. Hansoh has a wide range of products in areas such as oncology, anesthesia, antibiotics, anti-infectives, and cardiovascular diseases. It has expanded its research and development activities in recent years and has partnerships with other pharmaceutical companies. The company mainly sells its products to hospitals and medical facilities in China. It is committed to strong corporate governance and sustainability, and it has been recognized for its environmental initiatives. Overall, Hansoh Pharmaceutical Group Co Ltd is a major player in the Chinese pharmaceutical industry. Hansoh Pharmaceutical Group Company ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Hansoh Pharmaceutical Group Company's Return on Capital Employed (ROCE)

Hansoh Pharmaceutical Group Company's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Hansoh Pharmaceutical Group Company's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Hansoh Pharmaceutical Group Company's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Hansoh Pharmaceutical Group Company’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Hansoh Pharmaceutical Group Company stock

What is the ROCE (Return on Capital Employed) of Hansoh Pharmaceutical Group Company this year?

The ROCE of Hansoh Pharmaceutical Group Company is 0.1 undefined this year.

How has the ROCE (Return on Capital Employed) of Hansoh Pharmaceutical Group Company developed compared to the previous year?

The ROCE of Hansoh Pharmaceutical Group Company has increased by -9.43% decreased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Hansoh Pharmaceutical Group Company?

A high Return on Capital Employed (ROCE) indicates that Hansoh Pharmaceutical Group Company has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Hansoh Pharmaceutical Group Company?

A low ROCE (Return on Capital Employed) can indicate that Hansoh Pharmaceutical Group Company has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Hansoh Pharmaceutical Group Company impact the company?

An increase in the ROCE of Hansoh Pharmaceutical Group Company can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Hansoh Pharmaceutical Group Company affect the company?

A decrease in ROCE of Hansoh Pharmaceutical Group Company can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Hansoh Pharmaceutical Group Company?

Some factors that can affect Hansoh Pharmaceutical Group Company's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Hansoh Pharmaceutical Group Company so important for investors?

The ROCE of Hansoh Pharmaceutical Group Company is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Hansoh Pharmaceutical Group Company take to improve the ROCE?

To improve the ROCE, Hansoh Pharmaceutical Group Company can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Hansoh Pharmaceutical Group Company pay?

Over the past 12 months, Hansoh Pharmaceutical Group Company paid a dividend of 0.19 CNY . This corresponds to a dividend yield of about 1.15 %. For the coming 12 months, Hansoh Pharmaceutical Group Company is expected to pay a dividend of 0.2 CNY.

What is the dividend yield of Hansoh Pharmaceutical Group Company?

The current dividend yield of Hansoh Pharmaceutical Group Company is 1.15 %.

When does Hansoh Pharmaceutical Group Company pay dividends?

Hansoh Pharmaceutical Group Company pays a quarterly dividend. This is distributed in the months of October, July, October, July.

How secure is the dividend of Hansoh Pharmaceutical Group Company?

Hansoh Pharmaceutical Group Company paid dividends every year for the past 0 years.

What is the dividend of Hansoh Pharmaceutical Group Company?

For the upcoming 12 months, dividends amounting to 0.2 CNY are expected. This corresponds to a dividend yield of 1.23 %.

In which sector is Hansoh Pharmaceutical Group Company located?

Hansoh Pharmaceutical Group Company is assigned to the 'Health' sector.

Wann musste ich die Aktien von Hansoh Pharmaceutical Group Company kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Hansoh Pharmaceutical Group Company from 7/17/2024 amounting to 0.142 CNY, you needed to have the stock in your portfolio before the ex-date on 6/19/2024.

When did Hansoh Pharmaceutical Group Company pay the last dividend?

The last dividend was paid out on 7/17/2024.

What was the dividend of Hansoh Pharmaceutical Group Company in the year 2023?

In the year 2023, Hansoh Pharmaceutical Group Company distributed 0.23 CNY as dividends.

In which currency does Hansoh Pharmaceutical Group Company pay out the dividend?

The dividends of Hansoh Pharmaceutical Group Company are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Hansoh Pharmaceutical Group Company

Our stock analysis for Hansoh Pharmaceutical Group Company Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Hansoh Pharmaceutical Group Company Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.